CASE RECORD1:23-cv-04192•U.S. District Court, D. Del. (Wilmington)
COMMERCIAL CONTRACTSYNDICATING
Syntropy Cloud Solutions v. OmniCorp Enterprise Systems
Presiding Judge: Hon. Colm F. ConnollyFiling Date: 2023-08-19Est. Trial: 2025-09-20
Action Summary
Breach of enterprise exclusivity and misappropriation of proprietary distributed cloud routing algorithms. Clear documentary paper trail establishing intentional breach and vendor lock-out.
Asserted Patents / Causes
U.S. Patent No. 10,482,911
Lipid-Nanoparticle Conjugates
Primary Defense Arguments
35 U.S.C. § 103 Obviousness
12(b)(6) Dismissal Denied
Defendant Solvency & Verified Commercial Coverage
Audited insurance limits verify that defendant Meridian Pharma Global possesses adequate liquidity and policy coverage to satisfy a full jury verdict without bankruptcy risk.
Commercial Liability Limit (Verified):$50,000,000.00
Underwriting Rating
A Tier84.1 / 100
Target Funding:$2,200,000.00
Estimated Damages:$24,000,000.00
Funding Ratio:9.2% (Conservative)
Target Net IRR:22%
Agreed Return Multiple:2.25x
Non-Recourse Structure
Funding is contingent strictly on settlement or verdict proceeds. If litigation terminates with zero recovery, the claimant and counsel owe $0.00.